The Substance Abuse and Mental Health Services Administration (SAMHSA) wants to change its regulation requiring patients to consent to the release of their substance use disorder (SUD) treatment records. According to the SAMHSA proposal, which is now in the Office of Management and Budget and titled “Coordinating Care and Information Sharing in the Treatment of Substance Use … [Read more...] about SAMHSA to Propose Changes to 42 CFR Part 2
320
Teens Who Misuse Prescription Opioids More Likely to go on to Heroin: Link Not Necessarily Causal
Teens are more likely to use heroin if they misuse prescription opioids, a recent study of Los Angeles youth has found. The study did not make any conclusions about whether the association is causal, however. The researchers used a prospective longitudinal cohort study in 10 Los Angeles high schools. At baseline, all students had never used heroin. Initiation of heroin use was … [Read more...] about Teens Who Misuse Prescription Opioids More Likely to go on to Heroin: Link Not Necessarily Causal
Methadone Treatment and a Program for New Parents Approved for New Federal Child Welfare Law
The new clearinghouse for the Family First Prevention Services Act has approved another parent support program and a substance abuse treatment model. Methadone Maintenance Therapy (MMT) uses medically-prescribed methadone to reduce the use of heroin and other opioids by people struggling with addiction and dependency. Its inclusion on the original list of programs for review … [Read more...] about Methadone Treatment and a Program for New Parents Approved for New Federal Child Welfare Law
Orphan Drugs For Opioid Use Disorder: An Abuse Of The Orphan Drug Act
In November 2017, the drug company Indivior received Food and Drug Administration (FDA) approval for Sublocade, a once-monthly buprenorphine injection for patients with opioid use disorder. In December 2018, Braeburn Inc. received FDA approval for a similar product but could not sell it due to Indivior’s marketing exclusivity period. Typically, the FDA grants three years of … [Read more...] about Orphan Drugs For Opioid Use Disorder: An Abuse Of The Orphan Drug Act
UMass Researchers Receive $10 Million Grant To Study Jail-based Opioid Addiction Treatment Program
Researchers at the University of Massachusetts Amherst and the University of Massachusetts Medical School-Baystate are among the scientists at a dozen institutions nationwide that will form the Justice Community Opioid Innovation Network (JCOIN), an ambitious, $155 million effort to improve opioid addiction treatment in criminal justice settings, the National Institutes of … [Read more...] about UMass Researchers Receive $10 Million Grant To Study Jail-based Opioid Addiction Treatment Program
